- Home
- CVM vs IOBT Comparison
CVM vs IOBT Comparison
Compare CVM & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVM
- IOBT
- Stock Information
- Founded
- CVM 1983
- IOBT 2014
- Country
- CVM United States
- IOBT Denmark
- Employees
- CVM 44
- IOBT N/A
- Industry
- CVM Biotechnology: Biological Products (No Diagnostic Substances)
- IOBT Biotechnology: Pharmaceutical Preparations
- Sector
- CVM Health Care
- IOBT Health Care
- Exchange
- CVM Nasdaq
- IOBT Nasdaq
- Market Cap
- CVM 60.9M
- IOBT 50.5M
- IPO Year
- CVM 1987
- IOBT 2021
- Fundamental
- Price
- CVM $9.12
- IOBT $0.84
- Analyst Decision
- CVM
- IOBT Hold
- Analyst Count
- CVM 0
- IOBT 3
- Target Price
- CVM N/A
- IOBT $4.00
- AVG Volume (30 Days)
- CVM 82.9K
- IOBT 5.1M
- Earning Date
- CVM 08-14-2025
- IOBT 11-11-2025
- Dividend Yield
- CVM N/A
- IOBT N/A
- EPS Growth
- CVM N/A
- IOBT N/A
- EPS
- CVM N/A
- IOBT N/A
- Revenue
- CVM N/A
- IOBT N/A
- Revenue This Year
- CVM N/A
- IOBT N/A
- Revenue Next Year
- CVM N/A
- IOBT N/A
- P/E Ratio
- CVM N/A
- IOBT N/A
- Revenue Growth
- CVM N/A
- IOBT N/A
- 52 Week Low
- CVM $1.98
- IOBT $0.32
- 52 Week High
- CVM $32.70
- IOBT $2.79
- Technical
- Relative Strength Index (RSI)
- CVM 46.34
- IOBT 46.95
- Support Level
- CVM $8.61
- IOBT $0.62
- Resistance Level
- CVM $10.24
- IOBT $0.65
- Average True Range (ATR)
- CVM 0.68
- IOBT 0.09
- MACD
- CVM -0.13
- IOBT 0.06
- Stochastic Oscillator
- CVM 20.50
- IOBT 89.73
About CVM Cel-Sci Corporation
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.